Clinical pharmacology and practical aspects of isavuconazole use

Clinical pharmacology and practical aspects of isavuconazole use

The steadily increasing incidence of invasive fungal infections, influenced to some extent by the COVID-19 pandemic, caused by both yeast and molds makes it necessary to improve the antifungal therapies used. Historically, azoles have held a key position with respect to a range of clinical forms and...

Full description

Bibliographic Details
Main Author:	Veselov A.V.
Format:	Article
Language:	Russian
Published:	Interregional Association for Clinical Microbiology and Antimicrobial Chemotherapy 2023-12-01
Series:	Клиническая микробиология и антимикробная химиотерапия
Subjects:	antimycotics isavuconazole isavoconaznium triazoles aspergillosis mucormycosis
Online Access:	https://cmac-journal.ru/publication/2023/4/cmac-2023-t25-n4-p379/cmac-2023-t25-n4-p379.pdf

Similar Items

Role of isavuconazole in the treatment of invasive fungal infections
by: Wilson DT, et al.
Published: (2016-08-01)

Isavuconazole as salvage therapy for mucormycosis
by: Bianca Graves, et al.
Published: (2016-03-01)

Isavuconazole in the treatment of invasive aspergillosis and mucormycosis infections
by: Donnelley MA, et al.
Published: (2016-06-01)

Clinical research advances of isavuconazole in the treatment of invasive fungal diseases
by: Tingting Zhang, et al.
Published: (2022-12-01)

Pharmacoeconomic evaluation of isavuconazole, posaconazole, and voriconazole for the treatment of invasive mold diseases in hematological patients: initial therapy prior to pathogen differential diagnosis in China
by: Guangxin Han, et al.
Published: (2023-12-01)

Invasive Fungal Disease, Isavuconazole Treatment Failure, and Death in Acute Myeloid Leukemia Patients
by: Anne-Pauline Bellanger, et al.
Published: (2019-09-01)

Real-World Use of Isavuconazole as Primary Therapy for Invasive Fungal Infections in High-Risk Patients with Hematologic Malignancy or Stem Cell Transplant
by: Hiba Dagher, et al.
Published: (2022-01-01)

Successful outcome of disseminated mucormycosis in a 3-year-old child suffering from acute leukaemia: the role of isavuconazole? A case report
by: Marjorie Cornu, et al.
Published: (2018-12-01)

Isavuconazole for COVID-19-Associated Invasive Mold Infections
by: Nadir Ullah, et al.
Published: (2022-06-01)

Comparing the Real-World Use of Isavuconazole to Other Anti-Fungal Therapy for Invasive Fungal Infections in Patients with and without Underlying Disparities: A Multi-Center Retrospective Study
by: Marjorie Vieira Batista, et al.
Published: (2023-01-01)

Successful treatment of Rhizopus arrhizus rhino-orbital-cerebral mucormycosis with isavuconazole salvage therapy following extensive debridement
by: R.P. Miller, et al.
Published: (2021-06-01)

In Vitro Interaction between Isavuconazole and Tacrolimus, Cyclosporin A, or Sirolimus against <i>Aspergillus</i> Species
by: Patrick Schwarz, et al.
Published: (2020-07-01)

Isavuconazole: Mechanism of Action, Clinical Efficacy, and Resistance
by: Misti Ellsworth, et al.
Published: (2020-11-01)

Experience of Isavuconazole as a Salvage Therapy in Chronic Pulmonary Fungal Disease
by: Lisa Nwankwo, et al.
Published: (2022-03-01)

Isavuconazole—Animal Data and Clinical Data
by: Livio Pagano, et al.
Published: (2020-10-01)

Implementation of a Dual-Column Liquid Chromatography-Tandem Mass-Spectrometry Method for the Quantification of Isavuconazole in Clinical Practice
by: Dietmar Enko, et al.
Published: (2021-06-01)

Antifungal Resistance in Isolates of <i>Aspergillus</i> from a Pig Farm
by: John Kerr White, et al.
Published: (2021-06-01)

Successful Multimodal Therapy with Intracerebral Liposomal Amphotericin B and Systemic High-Dose Isavuconazole in Proven Disseminated Aspergillosis
by: Simon Feys, et al.
Published: (2023-03-01)

Diagnostic Aspects of Veterinary and Human Aspergillosis
by: Daniel Elad, et al.
Published: (2018-06-01)

Isavuconazole for Treating Invasive Mould Disease in Solid Organ Transplant Recipients
by: Jose Tiago Silva, et al.
Published: (2023-12-01)

Isavuconazole Treatment of Spinal Cord Invasive Aspergillosis Guided by Cerebrospinal Fluid (1,3)-β-d-Glucan Levels in a Patient with Low Interferon-Gamma and Ulcerative Colitis
by: Siobhan O’Regan, et al.
Published: (2022-05-01)

Population Pharmacokinetics of Isavuconazole in Critical Care Patients with COVID-19-Associated Pulmonary Aspergillosis and Monte Carlo Simulations of High Off-Label Doses
by: Lucas Perez, et al.
Published: (2023-02-01)

Isavuconazole in the Treatment of <i>Aspergillus fumigatus</i> Fracture-Related Infection: Case Report and Literature Review
by: Beatrijs Mertens, et al.
Published: (2022-03-01)

Novel treatment possibilities of invasive aspergillosis
by: G. A. Klyasova
Published: (2021-11-01)

Isavuconazole Treatment for Invasive Fungal Infections in Pediatric Patients
by: Philippe Zimmermann, et al.
Published: (2022-03-01)

Therapeutic Drug Monitoring of Isavuconazole: Serum Concentration Variability and Success Rates for Reaching Target in Comparison with Voriconazole
by: Malene Risum, et al.
Published: (2021-04-01)

Cerebral cryptococcoma successfully treated by isavuconazole in an immunocompetent patient: A case report
by: Luis Guilherme Ramanzini, et al.
Published: (2023-03-01)

A case of invasive pulmonary mucormycosis resulting from short courses of corticosteroids in a well-controlled diabetic patient
by: Kathy Hoang, et al.
Published: (2020-09-01)

Upper extremity Histoplasma capsulatum treatment with isavuconazole
by: Janet Le, et al.
Published: (2021-01-01)

Population Pharmacokinetics of Isavuconazole in Adult: A Systematic Review
by: Chen N, et al.
Published: (2023-12-01)

Isavuconazole Pharmacokinetics and Pharmacodynamics in Children
by: Hirsh Elhence, et al.
Published: (2022-12-01)

“ISAVUCONAZOL COMO ALTERNATIVA DE TRATAMENTO EM MUCORMICOSE DE ACOMETIMENTO RINO-ÓRBITO-CEREBRAL”
by: Igor Maia Marinho, et al.
Published: (2023-10-01)

Clinical and microbiological features and outcomes of mucormycosis in critically ill patients
by: Kathrin Rothe, et al.
Published: (2021-08-01)

Aspergillosis in patients with hematological malignancies
by: N. B. Bulieva
Published: (2014-07-01)

Aspergillosis in patients with hematological malignancies
by: N. B. Bulieva
Published: (2014-07-01)

Penetration of Isavuconazole in Ascites Fluid of Critically Ill Patients
by: Tobias Lahmer, et al.
Published: (2021-05-01)

Variability of Isavuconazole Trough Concentrations during Longitudinal Therapeutic Drug Monitoring
by: Léa Bolcato, et al.
Published: (2022-09-01)

In Vitro Synergy of Isavuconazole Combined With Colistin Against Common Candida Species
by: Patrick Schwarz, et al.
Published: (2022-04-01)

Successful treatment of Trichosporon asahii fungemia with isavuconazole in a patient with hematologic malignancies
by: Feugray G, et al.
Published: (2019-07-01)

Impact of the SARS-CoV-2 Pandemic in Candidaemia, Invasive Aspergillosis and Antifungal Consumption in a Tertiary Hospital
by: Juan Vicente Mulet Bayona, et al.
Published: (2021-05-01)